Company / EPS (Diluted)
Steris EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$1.07
FY2025
5-year range
$1.07 / $4.76
FY2021-FY2025
Trend
-56.9%
vs FY2024
Sector context
#74 of 159
Health Care
What the data says
At $1.07, Steris's eps (diluted) ranks #74 of 159 in the Health Care sector. EPS (Diluted) has declined for 3 consecutive years, from $4.76 in FY2022 to $1.07 in FY2025.
Based on SEC 10-K filings.
1.07 in FY2025 with a 5-year CAGR of -20.6%.
Declined from $4.63 to $1.07 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -39.2%
- 5-Year CAGR
- -20.6%
- 10-Year CAGR
- -
Sector benchmark
#74 of 159 in Health CareTop 47% of 159This company $1.07 Sector average $1.64
▼
-34.7% below sector average
Key checks
Key Insights
- Steris's eps (diluted) has declined for 3 consecutive years.
- In FY2025, eps (diluted) decreased 56.9% year-over-year.
- Ranks #74 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.07 | -56.9% |
| FY2024 | $2.48 | -46.4% |
| FY2023 | $4.63 | -2.7% |
| FY2022 | $4.76 | +34.1% |
| FY2021 | $3.55 | +4.7% |
| FY2020 | $3.39 | +164.8% |
| FY2019 | $1.28 | -63.9% |
| FY2018 | $3.55 | +373.3% |
| FY2017 | $0.75 | -41.4% |
| FY2016 | $1.28 | - |
As of FY2025 · SEC 10-K · Updated Mar 13, 2026